Annual report [Section 13 and 15(d), not S-K Item 405]

EQUITY - Schedule of Warrants (Details)

v3.25.0.1
EQUITY - Schedule of Warrants (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Dec. 23, 2024
Nov. 15, 2023
Jul. 31, 2024
Feb. 29, 2024
Jun. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
May 31, 2023
Derivative Warrants                  
Warrants                  
Balance at end of period (in shares)           21,400,000      
Weighted - Average Exercise Price Per Warrant                  
Balance at end of period (in dollars per share)         $ 1.00        
Warrants (derivative liabilities and equity)                  
Warrants                  
Balance at beginning of period (in shares)           86,931,558 86,048,837    
Granted (in shares)   200,000 19,400,000 1,800,000   21,900,000 2,970,221    
Cancelled (in shares)   (200,000)         (2,087,500)    
Reclassified (in shares)             0    
Cancelled/forfeited/expired (in shares) (35,862,922)         (36,913,022)      
Balance at end of period (in shares)           71,918,536 86,931,558 86,048,837  
Exercisable (in shares)           70,298,536      
Weighted - Average Exercise Price Per Warrant                  
Balance at beginning of period (in dollars per share)           $ 1.12 $ 1.40    
Granted (in dollars per share)   $ 0.55       0.99 0.63    
Cancelled (in dollars per share)   $ 1.75         2.18    
Cancelled/forfeited/expired (in dollars per share)           1.21      
Balance at end of period (in dollars per share)           1.03 $ 1.12 $ 1.40  
Exercisable (in dollars per share)           $ 1.04      
Aggregate Intrinsic Value                  
Outstanding           $ 0 $ 0 $ 1,081  
Exercisable           $ 0      
Weighted Average Remaining Contractual Life (in Years)                  
Outstanding           3 years 7 months 6 days 3 years 3 years 10 months 24 days  
Exercisable           3 years 7 months 6 days      
Warrants repriced (in shares)         5,890,922        
Warrants repriced (in dollars per share)         $ 1.00       $ 1.25
Reclassified (in dollars per share)         $ 1.00       $ 2.086
Warrants (derivative liabilities and equity) | Non-Derivative Warrants                  
Warrants                  
Balance at beginning of period (in shares)           49,068,636 30,673,635    
Granted (in shares)           2,500,000 2,970,221    
Cancelled (in shares)             (2,087,500)    
Reclassified (in shares)         17,512,280   17,512,280    
Cancelled/forfeited/expired (in shares)           (1,050,100)      
Balance at end of period (in shares)           50,518,536 49,068,636 30,673,635  
Exercisable (in shares)           48,898,536      
Warrants (derivative liabilities and equity) | Derivative Warrants                  
Warrants                  
Balance at beginning of period (in shares)           37,862,922 55,375,202    
Granted (in shares)           19,400,000 0    
Cancelled (in shares)             0    
Reclassified (in shares)         (17,512,280)   (17,512,280)    
Cancelled/forfeited/expired (in shares)           (35,862,922)      
Balance at end of period (in shares)           21,400,000 37,862,922 55,375,202  
Exercisable (in shares)           21,400,000